US FDA Advisory Committee Members Say Votes Should More Directly Affect Agency Decisions
Executive Summary
Survey of advisory committee members finds many believe an overwhelmingly negative vote should prevent a product approval. Survey was prompted by FDA accelerated approval of Alzheimer’s disease treatment Aduhelm despite overwhelming committee rejection.